Skip to main content

MARSHALL WACE, LLP

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1318757 LONDON, X0

Position in RIGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,372,413
-$1,807,727 QoQ
Shares Held
367,393
-38.6% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 156 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. RIGL ranks #52 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,372,413 367,393
2026-03-31 $16,180,140 598,378
2025-12-31 $26,280,487 613,600
2025-09-30 $17,035,763 601,333
2025-06-30 $6,910,433 368,950
2025-03-31 $3,809,345 211,748
2024-03-31 $649,071 438,562
2023-09-30 $38,898 36,017
2023-03-31 $228,004 172,731
2021-09-30 $251,275 69,222
2020-06-30 $49,966 27,304